SARS-CoV-2 Antibody Prevalence and Population-Based Death Rates, Greater Omdurman, Sudan

In a cross-sectional survey in Omdurman, Sudan, during March–April 2021, we estimated that 54.6% of the population had detectable severe acute respiratory syndrome coronavirus 2 antibodies. Overall population death rates among those >50 years of age increased 74% over the first coronavirus disease pandemic year.

[1]  A. Azman,et al.  SARS-CoV-2 Seroprevalence before Delta Variant Surge, Chattogram, Bangladesh, March–June 2021 , 2022, Emerging infectious diseases.

[2]  P. Formenty,et al.  Postmortem Surveillance for Ebola Virus Using OraQuick Ebola Rapid Diagnostic Tests, Eastern Democratic Republic of the Congo, 2019–2020 , 2022, Emerging infectious diseases.

[3]  Hongyue Li,et al.  Rapid Spread of Severe Fever with Thrombocytopenia Syndrome Virus by Parthenogenetic Asian Longhorned Ticks , 2022, Emerging infectious diseases.

[4]  DoKyoung Lee,et al.  Comparison of Complications after Coronavirus Disease and Seasonal Influenza, South Korea , 2022, Emerging infectious diseases.

[5]  B. Cowling,et al.  Serial Interval and Transmission Dynamics during SARS-CoV-2 Delta Variant Predominance, South Korea , 2021, Emerging infectious diseases.

[6]  B. Nunes,et al.  Comparative Effectiveness of Coronavirus Vaccine in Preventing Breakthrough Infections among Vaccinated Persons Infected with Delta and Alpha Variants , 2021, Emerging infectious diseases.

[7]  S. Madhi,et al.  Estimated SARS-CoV-2 infection rate and fatality risk in Gauteng Province, South Africa: a population-based seroepidemiological survey , 2021, International journal of epidemiology.

[8]  Tangchun Wu,et al.  Dynamics of the SARS-CoV-2 antibody response up to 10 months after infection , 2021, Cellular & Molecular Immunology.

[9]  J. Lessler,et al.  Seroprevalence of Severe Acute Respiratory Syndrome Coronavirus 2 IgG in Juba, South Sudan, 2020 , 2021, Emerging infectious diseases.

[10]  M. Mukhtar,et al.  The accelerating COVID-19 epidemic in Sudan , 2021, Nature Immunology.

[11]  L. Rénia,et al.  Dynamics of SARS-CoV-2 neutralising antibody responses and duration of immunity: a longitudinal study , 2021, The Lancet Microbe.

[12]  Stephen A. Rawlings,et al.  Longitudinal SARS-CoV-2 antibody study using the Easy Check COVID-19 IgM/IgG™ lateral flow assay , 2021, PloS one.

[13]  A. Estrada-Peña,et al.  Widespread Detection of Multiple Strains of Crimean-Congo Hemorrhagic Fever Virus in Ticks, Spain , 2021, Emerging infectious diseases.

[14]  S. Firestone,et al.  Bayesian latent class analysis when the reference test is imperfect. , 2021, Revue scientifique et technique.

[15]  H. Saya,et al.  Evaluation of the usability of various rapid antibody tests in the diagnostic application for COVID-19 , 2020, Annals of clinical biochemistry.

[16]  C. Whittaker,et al.  Report 39: Characterising COVID-19 epidemic dynamics and mortality under-ascertainment in Khartoum, Sudan , 2020 .

[17]  Y. Lawal.  Africa’s low COVID-19 mortality rate: A paradox? , 2020, International Journal of Infectious Diseases.

[18]  M. Campbell,et al.  Addressing Africa’s pandemic puzzle: Perspectives on COVID-19 transmission and mortality in sub-Saharan Africa , 2020, International Journal of Infectious Diseases.

[19]  A. Tewari,et al.  The Rapid Coronavirus Antibody Test: Can We Improve Accuracy? , 2020, Frontiers in Medicine.

[20]  J. Oloke,et al.  Laboratory diagnosis of COVID-19 in Africa: availability, challenges and implications. , 2020, Drug discoveries & therapeutics.

[21]  Polychronis Kostoulas,et al.  Bayesian latent class models to estimate diagnostic test accuracies of COVID‐19 tests , 2020, Journal of medical virology.

[22]  O. Keiser,et al.  Estimates of the COVID-19 Infection Fatality Rate for 48 African Countries: A Model-based Analysis , 2020, SSRN Electronic Journal.

[23]  David C. Yeo,et al.  Brief clinical evaluation of six high-throughput SARS-CoV-2 IgG antibody assays , 2020, Journal of Clinical Virology.

[24]  M. Hornef,et al.  Comparison of four new commercial serologic assays for determination of SARS-CoV-2 IgG , 2020, Journal of Clinical Virology.

[25]  Xiaoyan Lin,et al.  Bayesian hierarchical latent class models for estimating diagnostic accuracy , 2020, Statistical methods in medical research.

[26]  Seong-Jang Kim,et al.  Diagnostic test accuracy: application and practice using R software , 2019, Epidemiology and health.

[27]  K. Tufon,et al.  Comparative evaluation of a rapid diagnostic test, an antibody ELISA, and a pLDH ELISA in detecting asymptomatic malaria parasitaemia in blood donors in Buea, Cameroon , 2017, Infectious Diseases of Poverty.

[28]  Matthew J. Denwood,et al.  runjags: An R Package Providing Interface Utilities, Model Templates, Parallel Computing Methods and Additional Distributions for MCMC Models in JAGS , 2016 .

[29]  Karimollah Hajian-Tilaki,et al.  Sample size estimation in diagnostic test studies of biomedical informatics , 2014, J. Biomed. Informatics.

[30]  N. Walker,et al.  Diagnostic Accuracy and Optimal Use of Three Tests for Tuberculosis in Live Badgers , 2010, PloS one.

[31]  P. Rhodes.  Administration. , 1933, Teachers College Record: The Voice of Scholarship in Education.